A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer
This purpose of this study is to evaluate the use of two medications, docetaxel and lovastatin to determine the highest dose of lovastatin and docetaxel that can be given safely as well as the safety of combining the two drugs and the effect on the subject's tumor. Subjects can have any cancer.
Any Cancer|Breast Cancer
DRUG: Lovastatin|DRUG: Docetaxel
Incidence of Dose-limiting Toxicities (DLTs), To determine the maximum tolerated doses (MTD) of lovastatin and docetaxel in patients with various cancers having solid tumors., 27 weeks
The primary objective of this study is to determine the maximum tolerated dose (MTD) of lovastatin and docetaxel in patients with various different cancers.